188 related articles for article (PubMed ID: 26206265)
41. Internalization and down-regulation of the ALK receptor in neuroblastoma cell lines upon monoclonal antibodies treatment.
Mazot P; Cazes A; Dingli F; Degoutin J; Irinopoulou T; Boutterin MC; Lombard B; Loew D; Hallberg B; Palmer RH; Delattre O; Janoueix-Lerosey I; Vigny M
PLoS One; 2012; 7(3):e33581. PubMed ID: 22479414
[TBL] [Abstract][Full Text] [Related]
42. Expression of the heparin-binding growth factors Midkine and pleiotrophin during ocular development.
Cui R; Lwigale P
Gene Expr Patterns; 2019 Jun; 32():28-37. PubMed ID: 30825522
[TBL] [Abstract][Full Text] [Related]
43. Oncogenic tyrosine kinase NPM/ALK induces activation of the rapamycin-sensitive mTOR signaling pathway.
Marzec M; Kasprzycka M; Liu X; El-Salem M; Halasa K; Raghunath PN; Bucki R; Wlodarski P; Wasik MA
Oncogene; 2007 Aug; 26(38):5606-14. PubMed ID: 17353907
[TBL] [Abstract][Full Text] [Related]
44. Signal transducer and activator of transcription-3 activation contributes to high tissue inhibitor of metalloproteinase-1 expression in anaplastic lymphoma kinase-positive anaplastic large cell lymphoma.
Lai R; Rassidakis GZ; Medeiros LJ; Ramdas L; Goy AH; Cutler C; Fujio Y; Kunisada K; Amin HM; Gilles F
Am J Pathol; 2004 Jun; 164(6):2251-8. PubMed ID: 15161657
[TBL] [Abstract][Full Text] [Related]
45. Jak3 activation is significantly associated with ALK expression in anaplastic large cell lymphoma.
Lai R; Rassidakis GZ; Lin Q; Atwell C; Medeiros LJ; Amin HM
Hum Pathol; 2005 Sep; 36(9):939-44. PubMed ID: 16153455
[TBL] [Abstract][Full Text] [Related]
46. Targeted expression of mutated ALK induces neuroblastoma in transgenic mice.
Heukamp LC; Thor T; Schramm A; De Preter K; Kumps C; De Wilde B; Odersky A; Peifer M; Lindner S; Spruessel A; Pattyn F; Mestdagh P; Menten B; Kuhfittig-Kulle S; Künkele A; König K; Meder L; Chatterjee S; Ullrich RT; Schulte S; Vandesompele J; Speleman F; Büttner R; Eggert A; Schulte JH
Sci Transl Med; 2012 Jul; 4(141):141ra91. PubMed ID: 22764207
[TBL] [Abstract][Full Text] [Related]
47. Anaplastic lymphoma kinase (ALK)-induced malignancies: novel mechanisms of cell transformation and potential therapeutic approaches.
Wasik MA; Zhang Q; Marzec M; Kasprzycka M; Wang HY; Liu X
Semin Oncol; 2009 Apr; 36(2 Suppl 1):S27-35. PubMed ID: 19393833
[TBL] [Abstract][Full Text] [Related]
48. Phosphoproteomics reveals ALK promote cell progress via RAS/ JNK pathway in neuroblastoma.
Chen K; Lv F; Xu G; Zhang M; Wu Y; Wu Z
Oncotarget; 2016 Nov; 7(46):75968-75980. PubMed ID: 27732954
[TBL] [Abstract][Full Text] [Related]
49. Ethanol inhibits brain-derived neurotrophic factor stimulation of extracellular signal-regulated/mitogen-activated protein kinase in cerebellar granule cells.
Ohrtman JD; Stancik EK; Lovinger DM; Davis MI
Alcohol; 2006 May; 39(1):29-37. PubMed ID: 16938627
[TBL] [Abstract][Full Text] [Related]
50. Role of signal transducer and activator of transcription 5 in nucleophosmin/ anaplastic lymphoma kinase-mediated malignant transformation of lymphoid cells.
Nieborowska-Skorska M; Slupianek A; Xue L; Zhang Q; Raghunath PN; Hoser G; Wasik MA; Morris SW; Skorski T
Cancer Res; 2001 Sep; 61(17):6517-23. PubMed ID: 11522649
[TBL] [Abstract][Full Text] [Related]
51. Brefeldin A exerts differential effects on anaplastic lymphoma kinase positive anaplastic large cell lymphoma and classical Hodgkin lymphoma cell lines.
Toda T; Watanabe M; Kawato J; Kadin ME; Higashihara M; Kunisada T; Umezawa K; Horie R
Br J Haematol; 2015 Sep; 170(6):837-46. PubMed ID: 26105086
[TBL] [Abstract][Full Text] [Related]
52. Peptides derived from the dependence receptor ALK are proapoptotic for ALK-positive tumors.
Aubry A; Galiacy S; Ceccato L; Marchand C; Tricoire C; Lopez F; Bremner R; Racaud-Sultan C; Monsarrat B; Malecaze F; Allouche M
Cell Death Dis; 2015 May; 6(5):e1736. PubMed ID: 25950466
[TBL] [Abstract][Full Text] [Related]
53. Midkine-deficiency increases the anabolic response of cortical bone to mechanical loading.
Liedert A; Mattausch L; Röntgen V; Blakytny R; Vogele D; Pahl M; Bindl R; Neunaber C; Schinke T; Harroch S; Amling M; Ignatius A
Bone; 2011 Apr; 48(4):945-51. PubMed ID: 21185956
[TBL] [Abstract][Full Text] [Related]
54. FAM150A and FAM150B are activating ligands for anaplastic lymphoma kinase.
Guan J; Umapathy G; Yamazaki Y; Wolfstetter G; Mendoza P; Pfeifer K; Mohammed A; Hugosson F; Zhang H; Hsu AW; Halenbeck R; Hallberg B; Palmer RH
Elife; 2015 Sep; 4():e09811. PubMed ID: 26418745
[TBL] [Abstract][Full Text] [Related]
55. Brigatinib, an anaplastic lymphoma kinase inhibitor, abrogates activity and growth in ALK-positive neuroblastoma cells, Drosophila and mice.
Siaw JT; Wan H; Pfeifer K; Rivera VM; Guan J; Palmer RH; Hallberg B
Oncotarget; 2016 May; 7(20):29011-22. PubMed ID: 27049722
[TBL] [Abstract][Full Text] [Related]
56. Stimulation of ALK by the growth factor midkine renders glioma cells resistant to autophagy-mediated cell death.
Lorente M; Torres S; Salazar M; Carracedo A; Hernández-Tiedra S; Rodríguez-Fornés F; García-Taboada E; Meléndez B; Mollejo M; Campos-Martín Y; Barcia JA; Guzmán M; Velasco G
Autophagy; 2011 Sep; 7(9):1071-3. PubMed ID: 21593591
[TBL] [Abstract][Full Text] [Related]
57. JSI-124 (cucurbitacin I) inhibits Janus kinase-3/signal transducer and activator of transcription-3 signalling, downregulates nucleophosmin-anaplastic lymphoma kinase (ALK), and induces apoptosis in ALK-positive anaplastic large cell lymphoma cells.
Shi X; Franko B; Frantz C; Amin HM; Lai R
Br J Haematol; 2006 Oct; 135(1):26-32. PubMed ID: 16939498
[TBL] [Abstract][Full Text] [Related]
58. Targeting autophagy enhances the anti-tumoral action of crizotinib in ALK-positive anaplastic large cell lymphoma.
Mitou G; Frentzel J; Desquesnes A; Le Gonidec S; AlSaati T; Beau I; Lamant L; Meggetto F; Espinos E; Codogno P; Brousset P; Giuriato S
Oncotarget; 2015 Oct; 6(30):30149-64. PubMed ID: 26338968
[TBL] [Abstract][Full Text] [Related]
59. Growth Factor Midkine Promotes T-Cell Activation through Nuclear Factor of Activated T Cells Signaling and Th1 Cell Differentiation in Lupus Nephritis.
Masuda T; Maeda K; Sato W; Kosugi T; Sato Y; Kojima H; Kato N; Ishimoto T; Tsuboi N; Uchimura K; Yuzawa Y; Maruyama S; Kadomatsu K
Am J Pathol; 2017 Apr; 187(4):740-751. PubMed ID: 28183532
[TBL] [Abstract][Full Text] [Related]
60. Growth factor midkine is involved in the pathogenesis of diabetic nephropathy.
Kosugi T; Yuzawa Y; Sato W; Kawai H; Matsuo S; Takei Y; Muramatsu T; Kadomatsu K
Am J Pathol; 2006 Jan; 168(1):9-19. PubMed ID: 16400005
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
